Orthonotes
Orthonotes
by the.bonestories
v3.0 Fusion
v3.0 Fusion
tumor topic hub

Multiple Myeloma & Plasmacytoma

Most common primary malignant tumor of bone (plasma cell dyscrasia). CRAB features: hyperCalcemia, Renal failure, Anemia, Bone lesions (lytic). X‑ray: punched‑out lytic lesions, diffuse osteopenia, vertebral collapse. Diagnosis: serum/urine electrophoresis (M‑protein), bone marrow plasma cells >10%. Treatment: systemic chemotherapy (bortezomib, lenalidomide, dexamethasone), bisphosphonates, SCT in eligible patients.

Overview

Topic summary

View wiki
Most common primary malignant tumor of bone (plasma cell dyscrasia). CRAB features: hyperCalcemia, Renal failure, Anemia, Bone lesions (lytic). X‑ray: punched‑out lytic lesions, diffuse osteopenia, vertebral collapse. Diagnosis: serum/urine electrophoresis (M‑protein), bone marrow plasma cells >10%. Treatment: systemic chemotherapy (bortezomib, lenalidomide, dexamethasone), bisphosphonates, SCT in eligible patients.
MCQs

High-yield practice questions

Start topic quiz
Question 1

What is the most common primary malignant tumor of bone in adults?

Question 2

Which of the following is NOT a component of the CRAB criteria for diagnosing Multiple Myeloma?

Question 3

Which imaging modality is recommended as first-line for detecting bone involvement in Multiple Myeloma?

Question 4

What is the characteristic finding on X-ray for Multiple Myeloma?

Question 5

Which treatment is primarily used for solitary plasmacytoma?

Question 6

Which laboratory test is essential for diagnosing Multiple Myeloma?

Question 7

At what percentage of plasma cells in the bone marrow is Multiple Myeloma diagnosed according to the IMWG criteria?

Question 8

Which of the following is a poor prognostic factor in Multiple Myeloma?

Question 9

In terms of skeletal involvement in Multiple Myeloma, which site is most commonly affected?

Question 10

What is the typical calcium level that indicates hypercalcemia in the context of CRAB criteria?